Bristol-Myers Returns Plavix, Avapro Rights to Sanofi

Bristol-Myers Returns Plavix, Avapro Rights to Sanofi

J B Reed/Bloomberg

Bristol-Myers will get royalty payments on Sanofi’s sales of branded and unbranded Plavix and Avapro worldwide through 2018.